| Authors: |
Clowse MEB; Division of Rheumatology and Immunology, Duke University, Durham, NC, USA. Electronic address: megan.clowse@duke.edu., Isenberg DA; Department of Ageing, Rheumatology and Regenerative Medicine, Division of Medicine, University College London, London, UK., Merrill JT; Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Dörner T; Department of Medicine/Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany., Petri M; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Vital EM; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Morand EF; Centre for Inflammatory Diseases, Monash University and Monash Health, Melbourne, VIC, Australia., Touma Z; Division of Rheumatology, University of Toronto Lupus Clinic, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada., Askanase AD; Columbia University Medical Center, New York, NY, USA., Ioannou Y; UCB, Slough, UK., Brookes S; Biogen, Maidenhead, UK., Gaiha-Rohrbach J; Biogen, Cambridge, MA, USA., Koch ED; UCB, Monheim am Rhein, Germany., Zibian N; UCB, Colombes, France., Martin C; UCB, Slough, UK., Jimenez T; UCB, Raleigh, NC, USA., Nelde A; Biogen, Baar, Switzerland., Stach C; UCB, Monheim am Rhein, Germany. |
